- IHH Healthcare’s 2Q23 core earnings were flattish y-o-y at MYR315m, bringing 1H23 numbers to 46% and 40% of our and consensus’ estimates. Weaker-than-expected results were mainly due to higher cost of operations and utilities, as well as increased spending on repairs and maintenance.
- - Read this at SGinvestors.io -
IHH's 1H23 core earnings disappointed
- IHH Healthcare (SGX:Q0F)'s 1H23 core earnings disappointed, due to the consolidation of staff costs for its newly acquired entities, Ortopedia Hospital and Kent Health Group.
- - Read this at SGinvestors.io -
- Hospital revenue across key segments posted positive y-o-y growth, with total hospital and healthcare division revenue growth of 22% and 2% q-o-q. Key drivers were mainly the Turkey and Greater China divisions.
Segmental breakdown.
- Read more at SGinvestors.io.
Oong Chun Sung RHB Securities Research | https://www.rhbgroup.com/ 2023-08-30
Read also RHB's most recent report:
2023-09-01 IHH Healthcare - Growth To Be Anchored By Inorganic Expansion.
Price targets by 2 other brokers at IHH Healthcare Target Prices.
Listing of research reports at IHH Healthcare Analyst Reports.
Relevant links:
IHH Healthcare Share Price History,
IHH Healthcare Announcements,
IHH Healthcare Dividends & Corporate Actions,
IHH Healthcare News Articles
